 <h1>Requip Starter Kit Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>ropinirole</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about ropinirole. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Requip Starter Kit.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to ropinirole: oral tablet, oral tablet extended release</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, ropinirole (the active ingredient contained in Requip Starter Kit) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking ropinirole:</p><p>
<i>More common</i>
</p><ul>
<li>Confusion</li>
<li>dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position</li>
<li>drowsiness</li>
<li>falling</li>
<li>nausea</li>
<li>seeing, hearing, or feeling things that are not there (hallucinations)</li>
<li>sleepiness or unusual drowsiness</li>
<li>swelling of the legs</li>
<li>twisting, twitching, or other unusual body movements</li>
<li>unusual tiredness or weakness</li>
<li>worsening of parkinsonism</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Abdominal or stomach pain</li>
<li>bloating or swelling of the face, arms, hands, lower legs, or feet</li>
<li>blood in the urine</li>
<li>blurred vision</li>
<li>burning, pain, or difficulty in urinating</li>
<li>chest pain</li>
<li>chills</li>
<li>cold sweats</li>
<li>cough</li>
<li>double vision or other eye or vision problems</li>
<li>fainting</li>
<li>fear or nervousness</li>
<li>feeling of constant movement of self or surroundings</li>
<li>high or low blood pressure</li>
<li>irregular or pounding heartbeat</li>
<li>loss of memory</li>
<li>mental depression</li>
<li>pain</li>
<li>pain in the arms or legs</li>
<li>pounding in the ears</li>
<li>rapid weight gain</li>
<li>sensation of spinning</li>
<li>slow or fast heartbeat</li>
<li>sore throat</li>
<li>sweating</li>
<li>tightness in chest</li>
<li>tingling of the hands or feet</li>
<li>tingling, numbness, or prickly feelings</li>
<li>trouble in concentrating</li>
<li>troubled breathing</li>
<li>unusual weight gain or loss</li>
<li>vomiting</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Anxiety</li>
<li>buzzing or ringing in the ears</li>
<li>changes in vision</li>
<li>fever</li>
<li>headache</li>
<li>joint pain</li>
<li>loss of bladder control</li>
<li>muscle cramps, pain, or spasms</li>
<li>nasal congestion</li>
<li>runny nose</li>
<li>sneezing</li>
<li>trouble with swallowing</li>
<li>unusual urges</li>
</ul><p>
<i>Get emergency help immediately if any of the following symptoms of overdose occur while taking ropinirole:</i>
</p><p>
<i>Symptoms of overdose</i>
</p><ul>
<li>Agitation</li>
<li>grogginess</li>
<li>increase in unusual body movements, especially of the face or mouth</li>
<li>increased coughing</li>
<li>increased sweating</li>
<li>lack or loss of strength</li>
<li>nightmares</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of ropinirole may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>Less common</i>
</p><ul>
<li>Abnormal dreams</li>
<li>acid or sour stomach</li>
<li>back pain</li>
<li>belching</li>
<li>decrease in sexual desire or performance</li>
<li>difficulty having a bowel movement (stool)</li>
<li>dryness of mouth</li>
<li>flushing</li>
<li>general feeling of discomfort or illness</li>
<li>heartburn or gas</li>
<li>hot flashes</li>
<li>indigestion</li>
<li>loss of appetite</li>
<li>tremor</li>
<li>weight loss</li>
<li>yawning</li>
</ul><p>
<!-- end oral tablet, oral tablet extended release --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to ropinirole: oral kit, oral tablet, oral tablet extended release</i></p><h3>Gastrointestinal</h3><p>Parkinson's disease:</p>
<p><b>Very common</b> (10% or more): Nausea (up to 60%), vomiting (up to 12%)</p>
<p><b>Common</b> (1% to 10%): Dry mouth, abdominal pain, anorexia, dyspepsia, flatulence, constipation, diarrhea, dysphagia, increased saliva, heartburn</p>
<p></p>
<p>Restless Leg Syndrome: </p>
<p><b>Very common</b> (10% or more): Nausea (up to 40%), vomiting (up to 12.9%)</p>
<p><b>Common</b> (1% to 10%): Diarrhea, dyspepsia, dry mouth, abdominal pain upper</p>
<p><b>Uncommon</b> (0.1% to 1%):<sup>[Ref]</sup></p><h3>Nervous system</h3><p>Parkinson's disease</p>
<p><b>Very common</b> (10% or more): Dizziness (40%), somnolence (40%), dyskinesia (34%), headache (17%) </p>
<p><b>Common</b> (1% to 10%): Hyperkinesia, hypesthesia, hypokinesia, paresis, paresthesia, tremor</p>
<p><b>Uncommon</b> (0.1% to 1%): Sudden onset of sleep, excessive daytime somnolence</p>
<p></p>
<p>Restless Leg Syndrome: </p>
<p><b>Very common</b> (10% or more): Headache (up to 22.3%), somnolence (12%), dizziness (up to 12.9%)</p>
<p><b>Common</b> (1% to 10%): Paresthesia, migraine, paradoxical augmentation and rebound of restless leg syndrome<sup>[Ref]</sup></p><h3>Psychiatric</h3><p>Parkinson's disease</p>
<p><b>Very common</b> (10% or more): Hallucination (10%)</p>
<p><b>Common</b> (1% to 10%): Amnesia, impaired concentration, confusion, amnesia, anxiety, abnormal dreaming, nervousness </p>
<p><b>Uncommon</b> (0.1% to 1%): Psychotic reactions other than hallucinations, included delirium, delusions, paranoia</p>
<p><b>Frequency not reported</b>: Aggression</p>
<p><b>Postmarketing reports</b>: Impulse control disorders included pathological gambling and hypersexuality and increased libido </p>
<p></p>
<p>Restless Leg Syndrome: </p>
<p><b>Common</b> (1% to 10%): Nervousness </p>
<p><b>Postmarketing reports</b>: Impulse control disorders included pathological gambling and hypersexuality and increased libido<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p>Parkinson's disease:</p>
<p><b>Very common</b> (10% or more): Syncope (up to 12%)</p>
<p><b>Common</b> (1% to 10%): Hypertension, hypotension, orthostatic symptoms, chest pain, dependent edema, leg edema, flushing, extrasystoles, atrial fibrillation, palpitation, tachycardia, peripheral ischemia </p>
<p></p>
<p>Restless Leg Syndrome:</p>
<p><b>Common</b> (1% to 10%): Syncope</p>
<p><b>Uncommon</b> (0.1% to 1%): Orthostatic hypotension, peripheral edema</p>
<p><b>Frequency not reported</b>: Hypotension<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Common</b> (1% to 10%): Influenza, viral infection<sup>[Ref]</sup></p><h3>General</h3><p>The most commonly reported adverse reaction reported in patients with early Parkinson's disease included nausea, somnolence, dizziness, syncope, asthenic conditions, viral infection, leg edema, vomiting, and dyspepsia.  Among patients with advance Parkinson's disease, the more commonly reported adverse reactions included dyskinesia, somnolence, nausea, dizziness, confusion, hallucinations, sweating, and headache.</p>
<p></p>
<p>The most commonly reported adverse reactions in patients with restless legs syndrome included nausea, vomiting, somnolence, dizziness, and a asthenic condition.<sup>[Ref]</sup></p><h3>Respiratory</h3><p>Parkinson's disease</p>
<p><b>Common</b> (1% to 10%): Yawning, upper respiratory tract infection, dyspnea, bronchitis, pharyngitis, rhinitis, sinusitis</p>
<p></p>
<p>Restless Leg Syndrome: </p>
<p><b>Very common</b> (10% or more): Upper respiratory infection (10.7%)</p>
<p><b>Common</b> (1% to 10%): Nasopharyngitis, cough, nasal congestion, rhinitis, sinusitis<sup>[Ref]</sup></p><h3>Ocular</h3><p>Parkinson's disease:</p>
<p><b>Common</b> (1% to 10%): Eye abnormality, abnormal vision, xerophthalmia, diplopia<sup>[Ref]</sup></p><h3>Metabolic</h3><p>Parkinson's disease</p>
<p><b>Common</b> (1% to 10%): Decreased weight<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Common</b> (1% to 10%): Impotence, urinary tract infection, pyuria, urinary incontinence, urinary tract infection<sup>[Ref]</sup></p><h3>Other</h3><p>Parkinson's disease</p>
<p><b>Very common</b> (10% or more): Asthenic condition (16%)</p>
<p><b>Common</b> (1% to 10%): Pain, vertigo</p>
<p></p>
<p>Restless Leg Syndrome:</p>
<p><b>Very common</b> (10% or more): Fatigue (10.4%)</p>
<p><b>Common</b> (1% to 10%): Asthenic condition, vertigo</p>
<p><b>Postmarketing reports</b>:<sup>[Ref]</sup></p><p>Asthenic conditions include asthenia, fatigue, and/or malaise<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Arthralgia, arthritis, extremity pain, back pain, injury, myalgia<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Increased sweating<sup>[Ref]</sup></p><h3>Hematologic</h3><p>Parkinson's disease</p>
<p><b>Common</b> (1% to 10%): Anemia<sup>[Ref]</sup></p><h3>Hepatic</h3><p>Parkinson's disease</p>
<p><b>Common</b> (1% to 10%): Increased alkaline phosphatase</p>
<p><b>Frequency not reported</b>: Increased liver enzymes<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Frequency not reported</b>: Hypersensitivity reactions including urticarial, angioedema, rash, pruritus<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_2">2. "Product Information. Requip (ropinirole)." SmithKline Beecham, Philadelphia, PA. </p><p id="ref_3">3. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p></div>
<div class="more-resources" id="moreResources">
<h2>More about Requip Starter Kit (ropinirole)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>2 Reviews</li>
<li>Drug class: dopaminergic antiparkinsonism agents</li>
<li>FDA Alerts (1)</li>
</ul>
<h3>Consumer resources</h3>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Requip, Requip XL</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Parkinson's Disease</li>
<li>Periodic Limb Movement Disorder</li>
<li>Restless Legs Syndrome</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to ropinirole: oral kit, oral tablet, oral tablet extended release</i></p><h3>Gastrointestinal</h3><p>Parkinson's disease:</p><p><b>Very common</b> (10% or more): Nausea (up to 60%), vomiting (up to 12%)</p><p><b>Common</b> (1% to 10%): Dry mouth, abdominal pain, anorexia, dyspepsia, flatulence, constipation, diarrhea, dysphagia, increased saliva, heartburn</p><p></p><p>Restless Leg Syndrome: </p><p><b>Very common</b> (10% or more): Nausea (up to 40%), vomiting (up to 12.9%)</p><p><b>Common</b> (1% to 10%): Diarrhea, dyspepsia, dry mouth, abdominal pain upper</p><p><b>Uncommon</b> (0.1% to 1%):<sup>[Ref]</sup></p><h3>Nervous system</h3><p>Parkinson's disease</p><p><b>Very common</b> (10% or more): Dizziness (40%), somnolence (40%), dyskinesia (34%), headache (17%) </p><p><b>Common</b> (1% to 10%): Hyperkinesia, hypesthesia, hypokinesia, paresis, paresthesia, tremor</p><p><b>Uncommon</b> (0.1% to 1%): Sudden onset of sleep, excessive daytime somnolence</p><p></p><p>Restless Leg Syndrome: </p><p><b>Very common</b> (10% or more): Headache (up to 22.3%), somnolence (12%), dizziness (up to 12.9%)</p><p><b>Common</b> (1% to 10%): Paresthesia, migraine, paradoxical augmentation and rebound of restless leg syndrome<sup>[Ref]</sup></p><h3>Psychiatric</h3><p>Parkinson's disease</p><p><b>Very common</b> (10% or more): Hallucination (10%)</p><p><b>Common</b> (1% to 10%): Amnesia, impaired concentration, confusion, amnesia, anxiety, abnormal dreaming, nervousness </p><p><b>Uncommon</b> (0.1% to 1%): Psychotic reactions other than hallucinations, included delirium, delusions, paranoia</p><p><b>Frequency not reported</b>: Aggression</p><p><b>Postmarketing reports</b>: Impulse control disorders included pathological gambling and hypersexuality and increased libido </p><p></p><p>Restless Leg Syndrome: </p><p><b>Common</b> (1% to 10%): Nervousness </p><p><b>Postmarketing reports</b>: Impulse control disorders included pathological gambling and hypersexuality and increased libido<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p>Parkinson's disease:</p><p><b>Very common</b> (10% or more): Syncope (up to 12%)</p><p><b>Common</b> (1% to 10%): Hypertension, hypotension, orthostatic symptoms, chest pain, dependent edema, leg edema, flushing, extrasystoles, atrial fibrillation, palpitation, tachycardia, peripheral ischemia </p><p></p><p>Restless Leg Syndrome:</p><p><b>Common</b> (1% to 10%): Syncope</p><p><b>Uncommon</b> (0.1% to 1%): Orthostatic hypotension, peripheral edema</p><p><b>Frequency not reported</b>: Hypotension<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Common</b> (1% to 10%): Influenza, viral infection<sup>[Ref]</sup></p><h3>General</h3><p>The most commonly reported adverse reaction reported in patients with early Parkinson's disease included nausea, somnolence, dizziness, syncope, asthenic conditions, viral infection, leg edema, vomiting, and dyspepsia.  Among patients with advance Parkinson's disease, the more commonly reported adverse reactions included dyskinesia, somnolence, nausea, dizziness, confusion, hallucinations, sweating, and headache.</p><p></p><p>The most commonly reported adverse reactions in patients with restless legs syndrome included nausea, vomiting, somnolence, dizziness, and a asthenic condition.<sup>[Ref]</sup></p><h3>Respiratory</h3><p>Parkinson's disease</p><p><b>Common</b> (1% to 10%): Yawning, upper respiratory tract infection, dyspnea, bronchitis, pharyngitis, rhinitis, sinusitis</p><p></p><p>Restless Leg Syndrome: </p><p><b>Very common</b> (10% or more): Upper respiratory infection (10.7%)</p><p><b>Common</b> (1% to 10%): Nasopharyngitis, cough, nasal congestion, rhinitis, sinusitis<sup>[Ref]</sup></p><h3>Ocular</h3><p>Parkinson's disease:</p><p><b>Common</b> (1% to 10%): Eye abnormality, abnormal vision, xerophthalmia, diplopia<sup>[Ref]</sup></p><h3>Metabolic</h3><p>Parkinson's disease</p><p><b>Common</b> (1% to 10%): Decreased weight<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Common</b> (1% to 10%): Impotence, urinary tract infection, pyuria, urinary incontinence, urinary tract infection<sup>[Ref]</sup></p><h3>Other</h3><p>Parkinson's disease</p><p><b>Very common</b> (10% or more): Asthenic condition (16%)</p><p><b>Common</b> (1% to 10%): Pain, vertigo</p><p></p><p>Restless Leg Syndrome:</p><p><b>Very common</b> (10% or more): Fatigue (10.4%)</p><p><b>Common</b> (1% to 10%): Asthenic condition, vertigo</p><p><b>Postmarketing reports</b>:<sup>[Ref]</sup></p><p>Asthenic conditions include asthenia, fatigue, and/or malaise<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Arthralgia, arthritis, extremity pain, back pain, injury, myalgia<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Increased sweating<sup>[Ref]</sup></p><h3>Hematologic</h3><p>Parkinson's disease</p><p><b>Common</b> (1% to 10%): Anemia<sup>[Ref]</sup></p><h3>Hepatic</h3><p>Parkinson's disease</p><p><b>Common</b> (1% to 10%): Increased alkaline phosphatase</p><p><b>Frequency not reported</b>: Increased liver enzymes<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Frequency not reported</b>: Hypersensitivity reactions including urticarial, angioedema, rash, pruritus<sup>[Ref]</sup></p><p id="ref_1">1. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_2">2. "Product Information. Requip (ropinirole)." SmithKline Beecham, Philadelphia, PA. </p><p id="ref_3">3. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><h2>More about Requip Starter Kit (ropinirole)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>2 Reviews</li>
<li>Drug class: dopaminergic antiparkinsonism agents</li>
<li>FDA Alerts (1)</li>
</ul><h3>Consumer resources</h3><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Parkinson's Disease</li>
<li>Periodic Limb Movement Disorder</li>
<li>Restless Legs Syndrome</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>